Letters sent to healthcare professionals in December 2015

In December 2015, a letter was sent to healthcare professionals regarding Reminyl (galantamine hydrobromide).

• From: Medicines and Healthcare products Regulatory Agency
• Published: 21 January 2016

• Therapeutic area: Dermatology, Neurology

In December 2015, a letter was sent to healthcare professionals for:

• galantamine hydrobromide (Reminyl): risk of serious skin reactions

Published 21 January 2016